Treatment of type IIa and type V hyperlipoproteinemia and of a normal volunteer by continuous LDL-apheresis.
Riesen
W F
WF
Institute for Clinical & Experimental Cancer Research, University of Berne, Switzerland.
Sturzenegger
E
E
Imhof
C
C
Descoeudres
C
C
Mordasini
R
R
Oetliker
O H
OH
D000328:Adult; D001055:Apolipoproteins B / Q000097:blood; D002784:Cholesterol / Q000097:blood; D008076:Cholesterol, HDL / Q000097:blood; D008078:Cholesterol, LDL / Q000097:blood*; D015243:Cholesterol, VLDL; D006801:Humans; D006938:Hyperlipoproteinemia Type II / Q000097:blood / Q000628:therapy*; D006954:Hyperlipoproteinemia Type V / Q000097:blood / Q000628:therapy*; D008079:Lipoproteins, VLDL / Q000097:blood; D008297:Male; D008875:Middle Aged; D010956:Plasmapheresis
D001055:Apolipoproteins B; D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D015243:Cholesterol, VLDL; D008079:Lipoproteins, VLDL; D002784:Cholesterol